A comparative study on efficacy of chlorthalidone and azilsartan in confirmed cases of hypertension associated with ace gene polymorphism

https://doi.org/10.53730/ijhs.v6nS8.12518

Authors

  • Thota Madhu Chaithanya Assistant Professor, Dept of Pharmacology, RKDF Medical College, Bhopal, Madhya Pradesh
  • Naveen Choudary Gorantla Assistant professor, Department of Pharmacology, Guntur Medical College, Guntur, Andhra Pradesh
  • Syam Kumar Addepalli Assistant Professor, Department of Pharmacology, GITAM Institute of Medical Sciences and Research, (Deemed to be University) Visakhapatnam, Andhra Pradesh
  • Rajesh Kumar Manchi Assistant Professor, Department of Pharmacology, Saraswati Medical College, Madhuvihar, Ashakhera, Unnao, Uttar Pradesh-India
  • Manchi Haritha Ph.D., Research Scholar, Department of Pharmacology, Narayana Medical College, Chinthareddy Palem, Nellore, Andhra Pradesh

Keywords:

ACE gene, hypertension, Azilsartan, chlorthalidone

Abstract

The angiotensin-converting enzyme (ACE) gene consists of 26 exons, it is located on chromosome 17 and its polymorphism is a major contributing factor to hypertension. The aim is to compare the efficacy of Chlorthalidone and Azilsartan in newly diagnosed hypertension patients in association with ACE gene polymorphism. The study was conducted in the department of pharmacology, Rama medical college, Kanpur. After doing genetic test and basic investigation, 90 newly diagnosed patients with hypertension associated with ACE gene polymorphism were recruited, followed by grouping into two A&B. Group-A(n=45) patients were given Azilsartan 45mg/day and group-B(n=45) patients were given Chlorthalidone 25mg/day for 3 months. Systolic and diastolic blood pressure (SBP& DBP) was measured before and after 3 months of treatment in both groups and they were compared. Three genotypes were found in ACE gene polymorphism-associated hypertension cases such as I/I, I/D and D/D, the severity of hypertension is more in the D/D genotype followed by I/D and I/I genotypes. All three genotypes of both group-A & B had shown a significant mean reduction in SBP& DBP after 3 months of treatment (p<0.05) but the mean reduction was high in the I/I genotype followed by the I/D and then D/D genotype. 

Downloads

Download data is not yet available.

References

Beg, M., Dutta, S., Varma, A., Kant, R., Bawa, S., Anjoom, M., … Kumar, S. (2014). Study on drug prescribing pattern in hypertensive patients in a tertiary care teaching hospital at Dehradun, Uttarakhand. International Journal of Medical Science and Public Health, 3(8), 922. https://doi.org/10.5455/ijmsph.2014.170420146

Brook, R. D., & Rajagopalan, S. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American Society of Hypertension, 12(3), 238. https://doi.org/10.1016/j.jash.2018.01.004

Choudhury, I., Jothimalar, R., & Patra, A. K. (2012). Angiotensin converting enzyme gene polymorphism and its association with hypertension in South Indian population. Indian Journal of Clinical Biochemistry, 27(3), 265–269. https://doi.org/10.1007/s12291-012-0217-8

Crisan, D., & Carr, J. (2000). Angiotensin I-converting enzyme: Genotype and disease associations. Journal of Molecular Diagnostics, 2(3), 105–115. https://doi.org/10.1016/S1525-1578(10)60624-1

Dewi, P. S., Ratini, N. N., & Trisnawati, N. L. P. (2022). Effect of x-ray tube voltage variation to value of contrast to noise ratio (CNR) on computed tomography (CT) Scan at RSUD Bali Mandara. International Journal of Physical Sciences and Engineering, 6(2), 82–90. https://doi.org/10.53730/ijpse.v6n2.9656

Franklin, S. S., & Wong, N. D. (2013). Hypertension and cardiovascular disease: Contributions of the Framingham Heart Study. Global Heart, 8(1), 49–57. https://doi.org/10.1016/j.gheart.2012.12.004

Ghanta, M. K., Khan, A. K. A., & Bhaskar, L. V. K. S. (2021). Diagnostic and Prognostic Implications of Cardiac Markers for Hepatocellular Carcinoma. Critical ReviewsTM in Oncogenesis, 26(1), 1–10. https://doi.org/10.1615/CritRevOncog.2020036305

Jin, S. Y., Park, H. H., Li, G. Z., Lee, H. J., Hong, M. S., Hong, S. J., … Lee, M. H. (2004). Association of Angiotensin Converting Enzyme Gene I/D Polymorphism of Vitiligo in Korean Population. Pigment Cell Research, 17(1), 84–86. https://doi.org/10.1046/j.1600-0749.2003.00105.x

Liew, S. J., Lee, J. T., Tan, C. S., Koh, C. H. G., Van Dam, R., & Müller-Riemenschneider, F. (2019). Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: A cross-sectional study. BMJ Open, 9(5). https://doi.org/10.1136/bmjopen-2018-025869

Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., … Hong, Y. (2009). Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation, 119(3), 480–486. https://doi.org/10.1161/CIRCULATIONAHA.108.191259

Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367(9524), 1747–1757. https://doi.org/10.1016/S0140-6736(06)68770-9

Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16(3), 1215. https://doi.org/10.1093/nar/16.3.1215

Nuthalapati, P., Ghanta, M. K., Natesh, N. S., & L.V.K.S., B. (2021). Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection. BLOOD RESEARCH, 56(2), 61–64. https://doi.org/10.5045/br.2021.2021011

PR, R. (2014). Anti Hypertensive Prescribing Patterns and Cost Analysis for Primary Hypertension: A Retrospective Study. Journal of Clinical and Diagnostic Research. https://doi.org/10.7860/jcdr/2014/9567.4890

Qadar Pasha, M. A., Khan, A. P., Kumar, R., Ram, R. B., Grover, S. K., Srivastava, K. K., … Brahmachari, S. K. (2002). Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. Journal of Biosciences, 27(1 SUPPL. 1), 67–70. https://doi.org/10.1007/bf02703684

S.S., L., T., V., A.D., F., G., D., K., S. S. S. S., H., A.-R., … M., E. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2224–2260. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L366264682%5Cnhttp://dx.doi.org/10.1016/S0140-6736(12)61766-8%5Cnhttp://vb3lk7eb4t.search.serialssolutions.com?sid=EMBASE&issn=01406736&id=doi:10.1016%2FS0140-6736%2812%2961766-8&atitle=A+

Schelleman, H., Klungel, O. H., Van Duijn, C. M., Witteman, J. C. M., Hofman, A., De Boer, A., & Stricker, B. H. C. (2005). Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors. British Journal of Clinical Pharmacology, 59(4), 483–485. https://doi.org/10.1111/j.1365-2125.2004.02332.x

Sehajpal, P., Gupta, S., Agrawal, B., & Goel, R. (2009). Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India. Journal of Emergencies, Trauma, and Shock, 2(3), 150. https://doi.org/10.4103/0974-2700.55323

Siragy, H. M. (2003). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Current Hypertension Reports, 5(4), 293–294. https://doi.org/10.1007/s11906-003-0036-7

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Tikhomirova, V. E., Kost, O. A., Kryukova, O. V., Golukhova, E. Z., Bulaeva, N. I., Zholbaeva, A. Z., … Danilov, S. M. (2017). ACE phenotyping in human heart. PLoS ONE, 12(8). https://doi.org/10.1371/journal.pone.0181976

Tiwari, H., Kumar, A., & Kulkarni, S. K. (2004). Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Medical Journal, 45(3), 117–120.

Tunstall-Pedoel, H., Chen, R., & Kramarz, P. (2004). Prevalence of individuals with both raised blood pressure and raised cholesterol in WHO MONICA project population surveys 1989–1997. Euro Heart, 25(3), 234.

Xavier, D., Mathew, N., Pradeep, J., & Pais, P. (2001). Pattern of drug use in hypertension in a tertiary hospital: A cross sectional study in the in-patient wards. Indian Journal of Pharmacology, 33(6), 456–457.

Yitno, Y., Farida, F., Islamy, A., Livana, P. H., & Farasari, P. (2022). Relationship compliance with dietary approch to stop hypertension pattern with blood pressure in hypertension patients at Puskesmas Tulungagung, Tulungagung Regency . International Journal of Health Sciences, 6(S3), 10625–10632. https://doi.org/10.53730/ijhs.v6nS3.9581

Published

05-07-2021

How to Cite

Chaithanya, T. M., Gorantla, N. C., Addepalli, S. K., Manchi, R. K., & Haritha, M. (2021). A comparative study on efficacy of chlorthalidone and azilsartan in confirmed cases of hypertension associated with ace gene polymorphism. International Journal of Health Sciences, 6(S8), 2551–2560. https://doi.org/10.53730/ijhs.v6nS8.12518

Issue

Section

Peer Review Articles